tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
GMAB is currently covered by 5 analysts with an average price target of $39.3. This is a potential upside of $9.23 (17.49%) from yesterday's end of day stock price of $33.45.
Genmab AS's activity chart (see below) currently has 146 price targets and 134 ratings on display. The stock rating distribution of GMAB is 14.29% HOLD and 85.71% BUY.
Analysts average stock forecasts to be materialized ratio is 34.73% with an average time for these price targets to be met of 73 days.
Highest price target for GMAB is $43, Lowest price target is $32, average price target is $39.3.
Most recent stock forecast was given by MICHAEL SCHMIDT from GUGGENHEIM on 07-Aug-2026.
Currently out of the existing stock ratings of GMAB, 3 are a HOLD (14.29%), 18 are a BUY (85.71%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 23-Feb-2026
$42
$8.55 (25.56%)
$40
Hold Since 02-May-2022
$43
$9.55 (28.55%)
$32
Buy Since 01-Feb-2022
$40
$6.55 (19.58%)
$38
Buy Since 13-Jan-2020
$40
$13.88 (53.14%)
Buy Since 03-Jun-2025
$39
$12.88 (49.31%)
$34
What is GMAB (Genmab AS) average time for price targets to be met?
Which analyst has the current highest performing score on GMAB (Genmab AS) with a proven track record?
Which analyst has the most public recommendations on GMAB (Genmab AS)?
Which analyst is the currently most bullish on GMAB (Genmab AS)?
Which analyst is the currently most reserved on GMAB (Genmab AS)?
